Literature DB >> 35070892

A systematic review and meta-analysis of the correlation between hyperuricemia and thyroid nodules in adults.

Jingyan Hu1, Ying Luo1, Xuebo Lin1.   

Abstract

BACKGROUND: In recent years, thyroid nodules have gradually become one of the important factors endangering people's health, and we hope to recognize the association between hyperuricemia and thyroid nodulogenesis by this meta-analysis study.
METHODS: Literatures related to hyperuricemia and thyroid nodules were searched in the Chinese biomedical databases Chinese National Knowledge Infrastructure (CNKI), VIP, Wanfang, and the Chinese Biomedical Literature Database (CBM), as well as the English databases PubMed, EMBASE, and the Cochrane Library from establishment of the databases to September 2021. Duplicate literatures were identified using Endnote X9 software and excluded. All studies were screened according to the inclusion and exclusion criteria, and the quality of the included literature was assessed. Data were recorded and meta-analyzed using the Stata 15.1 software. Odds ratios (OR) and 95% confidence intervals (CIs) were calculated using the fixed effects or random effects models. Finally, sensitivity analyses were performed to assess the reliability of the results. Funnel plots were constructed to evaluate the publication bias of the literatures.
RESULTS: A total of 16 articles, with a total sample size of 126,907, were included in this study. Meta-analysis showed that there was no correlation between the incidence of thyroid nodules and the presence or absence of hyperuricemia in the overall population. Interestingly, hyperuricemia was found to be a protective factor for the incidence of thyroid nodules in the male population (OR =0.91; 95% CI: 0.86 to 0.97; P<0.05). However, hyperuricemia was identified as a risk factor for the incidence of thyroid nodules in the female population (OR =1.14; 95% CI: 1.04 to 1.25; P<0.05). DISCUSSION: Serum uric acid has a bidirectional regulatory effect in different genders and female patients should be wary of secondary thyroid nodules. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Hyperuricemia; adult thyroid nodule; correlation; meta-analysis

Year:  2021        PMID: 35070892      PMCID: PMC8749089          DOI: 10.21037/gs-21-722

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  11 in total

Review 1.  The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease.

Authors:  Richard J Johnson; Eric A Gaucher; Yuri Y Sautin; George N Henderson; Alex J Angerhofer; Steven A Benner
Journal:  Med Hypotheses       Date:  2008-03-10       Impact factor: 1.538

2.  The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.

Authors:  Y Itahana; R Han; S Barbier; Z Lei; S Rozen; K Itahana
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

3.  A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer.

Authors:  Saloua Lassoued; Malek Mseddi; Fatma Mnif; Mohamed Abid; Fadhel Guermazi; Hatem Masmoudi; Abdelfatteh El Feki; Hamadi Attia
Journal:  Biol Trace Elem Res       Date:  2010-03-05       Impact factor: 3.738

4.  The effect of pregnancy on thyroid nodule formation.

Authors:  A W C Kung; M T Chau; T T Lao; S C F Tam; L C K Low
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.

Authors:  Akiko Ichikawa; Hiroyuki Sumino; Tetsuya Ogawa; Shuichi Ichikawa; Kosaku Nitta
Journal:  Geriatr Gerontol Int       Date:  2008-12       Impact factor: 2.730

6.  Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease.

Authors:  Ryota Yoshitomi; Akiko Fukui; Masaru Nakayama; Yoriko Ura; Hirofumi Ikeda; Hideyuki Oniki; Takuya Tsuchihashi; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Hypertens Res       Date:  2013-10-03       Impact factor: 3.872

7.  Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects.

Authors:  Elisa Fabbrini; Mauro Serafini; Irena Colic Baric; Stanley L Hazen; Samuel Klein
Journal:  Diabetes       Date:  2013-12-18       Impact factor: 9.461

8.  The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid.

Authors:  Yao Liu; Ziwei Lin; Chunjun Sheng; Yikun Zhu; Yun Huang; Ni Zhong; Zhao Jia; Shen Qu
Journal:  Oncotarget       Date:  2017-06-20

9.  Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study.

Authors:  Xiaoying Ding; Ying Xu; Yufan Wang; Xiaohua Li; Chunhua Lu; Jing Su; Yuting Chen; Yuhang Ma; Yanhua Yin; Yong Wu; Yaqiong Jin; Lihua Yu; Junyi Jiang; Naisi Zhao; Qingwu Yan; Andrew S Greenberg; Haiyan Sun; Mingyu Gu; Li Zhao; Yunhong Huang; Yijie Wu; Chunxian Qian; Yongde Peng
Journal:  Mediators Inflamm       Date:  2017-05-21       Impact factor: 4.711

10.  Sex-specific association of serum uric acid dynamics with the incidence of metabolic syndrome in a health check-up Chinese population: a prospective cohort study.

Authors:  Ying Liu; Yongjun Fan; Qigui Liu; Kehua Liu; Fangfang Chen; Xiao Tang; Guorong Li; Dongmei Hu; Guirong Song
Journal:  BMJ Open       Date:  2020-07-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.